Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 12 (5) , 194-199
- https://doi.org/10.1016/0165-6147(91)90546-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Antiatherosclerotic agents. A structurally novel bivalent inhibitor of AcylCoA:cholesterol O-acyltransferase with systemic activityJournal of Medicinal Chemistry, 1990
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- Inhibition of acyl coenzyme A: Cholesterol acyltransferase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Inhibition of cellular cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblastsBiochemical and Biophysical Research Communications, 1987
- Mechanism of the Inhibition of Cholesterol Absorption by DL-Melinamide: Inhibition of Cholesterol EsterificationThe Japanese Journal of Pharmacology, 1986
- Dietary cyclandelate decreases pre-established atherosclerosis in the rabbitAtherosclerosis, 1984
- Potential antiatherosclerotic agents. 3. Substituted benzoic and nonbenzoic acid analogs of cetabenJournal of Medicinal Chemistry, 1983
- LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in AtherosclerosisAnnual Review of Biochemistry, 1983
- Cetaben Sodium, an Antiatherosclerotic AgentJournal of Pharmaceutical Sciences, 1979